-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UmvDUlolqBYXAh3Qz1cQU2zdH41mm/N7RupbTF9oCkAoyOrGm5uMZaanpAWxEWMK jVSywosaAm9p3iNUA4RD5g== 0001104659-05-057065.txt : 20051121 0001104659-05-057065.hdr.sgml : 20051121 20051121172118 ACCESSION NUMBER: 0001104659-05-057065 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051116 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20051121 DATE AS OF CHANGE: 20051121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARIES VENTURES INC CENTRAL INDEX KEY: 0000772320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840987840 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-14136 FILM NUMBER: 051218916 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE, SUITE 525 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 794-3420 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE, SUITE 525 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CASMYN CORP DATE OF NAME CHANGE: 19941229 FORMER COMPANY: FORMER CONFORMED NAME: SUMMA METALS CORP DATE OF NAME CHANGE: 19940503 FORMER COMPANY: FORMER CONFORMED NAME: FINTECH INC DATE OF NAME CHANGE: 19940503 8-K 1 a05-20725_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT
pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

DATE OF REPORT (Date of earliest event reported): November 16, 2005

 

000-14136

(Commission file number)

 

ARIES VENTURES INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

84-0987840

(State of incorporation)

 

(IRS Employer Identification No.)

 

 

 

3611 Valley Centre Drive, Suite 525

 

 

San Diego, California 92130

 

(858) 436-1000

(Address of principal executive offices)

 

(Registrant’s telephone number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


 

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

 

On November 16, 2005, the Board of Directors of Aries Ventures Inc. (the “Company”) appointed Dennis J. Mulroy to the position of Chief Financial Officer.  He will also serve as Chief Financial Officer of Cardium Therapeutics, Inc., the Company’s wholly owned subsidiary. Mr. Mulroy brings to the Company over 20 years of corporate financial experience spanning several industries, having served most recently as Chief Financial Officer at Molecular Imaging Corporation, a publicly-traded diagnostic services company.  Previously he held senior financial positions at public and privately-held companies, including SeraCare Life Sciences Inc., Bioceutix Inc., Bidland Systems, FirstWorld Communications Inc., River Medical Inc., IVAC Holding Inc.,  Spectragrahics Corporation and IMED Corporation.  He is a Certified Public Accountant in the State Of California and began his career with Ernst & Young.  Mr. Mulroy earned a Bachelor of Business Administration from the University of San Diego.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ARIES VENTURES INC.

 

 

 

Date: November 18, 2005

By:

/s/ Christopher J. Reinhard

 

 

Christopher J. Reinhard

 

 

Chief Executive Officer

 

2

 -----END PRIVACY-ENHANCED MESSAGE-----